Clinical Trials · NCT02656810
A Comparison Study of PF708 and Forteo in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Pfenex, Inc
- Enrollment
- 70
- Start date
- Dec 2015
- Locations
- 1 site, United States
- Primary endpoint
- Serum area-under-the-curve (AUC) of PF708 and Forteo